{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:32:30Z","timestamp":1794918750310,"version":"4.9.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microbiome"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that is thought to involve alterations in the gut microbiome, but robust microbial signatures have been challenging to identify. As prior studies have primarily focused on composition, we hypothesized that multi-omics assessment of microbial function incorporating both metatranscriptomics and metabolomics would further delineate microbial profiles of IBS and its subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Fecal samples were collected from a racially\/ethnically diverse cohort of 495 subjects, including 318 IBS patients and 177 healthy controls, for analysis by 16S rRNA gene sequencing (\n                      <jats:italic>n<\/jats:italic>\n                      = 486), metatranscriptomics (\n                      <jats:italic>n<\/jats:italic>\n                      = 327), and untargeted metabolomics (\n                      <jats:italic>n<\/jats:italic>\n                      = 368). Differentially abundant microbes, predicted genes, transcripts, and metabolites in IBS were identified by multivariate models incorporating age, sex, race\/ethnicity, BMI, diet, and HAD-Anxiety. Inter-omic functional relationships were assessed by transcript\/gene ratios and microbial metabolic modeling. Differential features were used to construct random forests classifiers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      IBS was associated with global alterations in microbiome composition by 16S rRNA sequencing and metatranscriptomics, and in microbiome function by predicted metagenomics, metatranscriptomics, and metabolomics. After adjusting for age, sex, race\/ethnicity, BMI, diet, and anxiety, IBS was associated with differential abundance of bacterial taxa such as\n                      <jats:italic>Bacteroides dorei<\/jats:italic>\n                      ; metabolites including increased tyramine and decreased gentisate and hydrocinnamate; and transcripts related to fructooligosaccharide and polyol utilization. IBS further showed transcriptional upregulation of enzymes involved in fructose and glucan metabolism as well as the succinate pathway of carbohydrate fermentation. A multi-omics classifier for IBS had significantly higher accuracy (AUC 0.82) than classifiers using individual datasets. Diarrhea-predominant IBS (IBS-D) demonstrated shifts in the metatranscriptome and metabolome including increased bile acids, polyamines, succinate pathway intermediates (malate, fumarate), and transcripts involved in fructose, mannose, and polyol metabolism compared to constipation-predominant IBS (IBS-C). A classifier incorporating metabolites and gene-normalized transcripts differentiated IBS-D from IBS-C with high accuracy (AUC 0.86).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>IBS is characterized by a multi-omics microbial signature indicating increased capacity to utilize fermentable carbohydrates\u2014consistent with the clinical benefit of diets restricting this energy source\u2014that also includes multiple previously unrecognized metabolites and metabolic pathways. These findings support the need for integrative assessment of microbial function to investigate the microbiome in IBS and identify novel microbiome-related therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40168-022-01450-5","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T22:02:58Z","timestamp":1673301778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes"],"prefix":"10.1186","volume":"11","author":[{"given":"Jonathan P.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venu","family":"Lagishetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan C.","family":"Hauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Labus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien S.","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momchilo","family":"Vuyisich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Naliboff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpana","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Tillisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeran A.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"issue":"9","key":"1450_CR1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jama.2015.0954","volume":"313","author":"WD Chey","year":"2015","unstructured":"Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949\u201358.","journal-title":"JAMA"},{"key":"1450_CR2","doi-asserted-by":"publisher","first-page":"101634","DOI":"10.1016\/j.bpg.2019.101634","volume":"40-41","author":"PM Hellstrom","year":"2019","unstructured":"Hellstrom PM, Benno P. The Rome IV: irritable bowel syndrome - a functional disorder. Best Pract Res Clin Gastroenterol. 2019;40-41:101634.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"1450_CR3","doi-asserted-by":"publisher","first-page":"G52","DOI":"10.1152\/ajpgi.00338.2016","volume":"312","author":"Y Bhattarai","year":"2017","unstructured":"Bhattarai Y, Muniz Pedrogo DA, Kashyap PC. Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol. 2017;312(1):G52\u201362.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1450_CR4","doi-asserted-by":"crossref","unstructured":"De Palma G, Lynch MD, Lu J, Dang VT, Deng Y, Jury J, et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med. 2017;9(379):eaaf6397.","DOI":"10.1126\/scitranslmed.aaf6397"},{"issue":"4","key":"1450_CR5","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1111\/nmo.12103","volume":"25","author":"L Crouzet","year":"2013","unstructured":"Crouzet L, Gaultier E, Del'Homme C, Cartier C, Delmas E, Dapoigny M, et al. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil. 2013;25(4):e272\u201382.","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"1450_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2016.09.049","volume":"152","author":"J Tap","year":"2017","unstructured":"Tap J, Derrien M, Tornblom H, Brazeilles R, Cools-Portier S, Dore J, et al. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology. 2017;152(1):111\u2013123 e118.","journal-title":"Gastroenterology"},{"key":"1450_CR7","doi-asserted-by":"crossref","unstructured":"Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med. 2018;10(472):eaap8914.","DOI":"10.1126\/scitranslmed.aap8914"},{"issue":"6","key":"1450_CR8","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/gutjnl-2019-318717","volume":"69","author":"LW Hugerth","year":"2020","unstructured":"Hugerth LW, Andreasson A, Talley NJ, Forsberg AM, Kjellstrom L, Schmidt PT, et al. No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population. Gut. 2020;69(6):1076\u201384.","journal-title":"Gut"},{"issue":"1","key":"1450_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","volume":"157","author":"R Pittayanon","year":"2019","unstructured":"Pittayanon R, Lau JT, Yuan Y, Leontiadis GI, Tse F, Surette M, et al. Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review. Gastroenterology. 2019;157(1):97\u2013108.","journal-title":"Gastroenterology"},{"issue":"1","key":"1450_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40168-017-0260-z","volume":"5","author":"JS Labus","year":"2017","unstructured":"Labus JS, Hollister EB, Jacobs J, Kirbach K, Oezguen N, Gupta A, et al. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome. Microbiome. 2017;5(1):49.","journal-title":"Microbiome"},{"issue":"6","key":"1450_CR11","doi-asserted-by":"publisher","first-page":"e0121521","DOI":"10.1128\/mSystems.01215-21","volume":"6","author":"J Phan","year":"2021","unstructured":"Phan J, Nair D, Jain S, Montagne T, Flores DV, Nguyen A, et al. Alterations in gut microbiome composition and function in irritable bowel syndrome and increased probiotic abundance with daily supplementation. mSystems. 2021;6(6):e0121521.","journal-title":"mSystems"},{"issue":"6","key":"1450_CR12","doi-asserted-by":"publisher","first-page":"e13884","DOI":"10.1111\/nmo.13884","volume":"32","author":"SM Bennet","year":"2020","unstructured":"Bennet SM, Keshteli AH, Bercik P, Madsen KL, Reed D, Vanner SJ. Application of metabolomics to the study of irritable bowel syndrome. Neurogastroenterol Motil. 2020;32(6):e13884.","journal-title":"Neurogastroenterol Motil"},{"key":"1450_CR13","doi-asserted-by":"crossref","unstructured":"Ahluwalia B, Iribarren C, Magnusson MK, Sundin J, Clevers E, Savolainen O, et al. A distinct faecal microbiota and metabolite profile linked to bowel habits in patients with irritable bowel syndrome. Cells. 2021;10(6):1459.","DOI":"10.3390\/cells10061459"},{"issue":"6","key":"1450_CR14","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.cell.2020.08.007","volume":"182","author":"RAT Mars","year":"2020","unstructured":"Mars RAT, Yang Y, Ward T, Houtti M, Priya S, Lekatz HR, et al. Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome. Cell. 2020;182(6):1460\u20131473 e1417.","journal-title":"Cell"},{"key":"1450_CR15","doi-asserted-by":"crossref","unstructured":"Han L, Zhao L, Zhou Y, Yang C, Xiong T, Lu L, et al. Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity. ISME J. 2021;16(4):983-96.","DOI":"10.1038\/s41396-021-01123-5"},{"issue":"4","key":"1450_CR16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1053\/j.gastro.2019.11.301","volume":"158","author":"IB Jeffery","year":"2020","unstructured":"Jeffery IB, Das A, O'Herlihy E, Coughlan S, Cisek K, Moore M, et al. Differences in fecal microbiomes and metabolomes of people with vs without irritable bowel syndrome and bile acid malabsorption. Gastroenterology. 2020;158(4):1016\u20131028 e1018.","journal-title":"Gastroenterology"},{"issue":"2","key":"1450_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1053\/j.gastro.2020.10.058","volume":"160","author":"RAT Mars","year":"2021","unstructured":"Mars RAT, Frith M, Kashyap PC. Functional gastrointestinal disorders and the microbiome-what is the best strategy for moving microbiome-based therapies for functional gastrointestinal disorders into the clinic? Gastroenterology. 2021;160(2):538\u201355.","journal-title":"Gastroenterology"},{"issue":"1","key":"1450_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s40168-021-01188-6","volume":"9","author":"JP Jacobs","year":"2021","unstructured":"Jacobs JP, Gupta A, Bhatt RR, Brawer J, Gao K, Tillisch K, et al. Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome. 2021;9(1):236.","journal-title":"Microbiome"},{"issue":"5","key":"1450_CR19","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","volume":"130","author":"DA Drossman","year":"2006","unstructured":"Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130(5):1377\u201390.","journal-title":"Gastroenterology"},{"issue":"3","key":"1450_CR20","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1016\/j.cgh.2021.05.027","volume":"20","author":"A Lenhart","year":"2022","unstructured":"Lenhart A, Dong T, Joshi S, Jaffe N, Choo C, Liu C, et al. Effect of exclusion diets on symptom severity and the gut microbiota in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2022;20(3):e465\u201383.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1450_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","volume":"11","author":"CY Francis","year":"1997","unstructured":"Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395\u2013402.","journal-title":"Aliment Pharmacol Ther"},{"key":"1450_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/0471142735.im0741s107","volume":"107","author":"M Tong","year":"2014","unstructured":"Tong M, Jacobs JP, McHardy IH, Braun J. Sampling of intestinal microbiota and targeted amplification of bacterial 16S rRNA genes for microbial ecologic analysis. Curr Protoc Immunol. 2014;107:7\u201341.","journal-title":"Curr Protoc Immunol"},{"issue":"6","key":"1450_CR23","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jcmgh.2016.06.004","volume":"2","author":"JP Jacobs","year":"2016","unstructured":"Jacobs JP, Goudarzi M, Singh N, Tong M, McHardy IH, Ruegger P, et al. A disease-associated microbial and metabolomics state in relatives of pediatric inflammatory bowel disease patients. Cell Mol Gastroenterol Hepatol. 2016;2(6):750\u201366.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"7","key":"1450_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581\u20133.","journal-title":"Nat Methods"},{"issue":"6","key":"1450_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","volume":"38","author":"GM Douglas","year":"2020","unstructured":"Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, et al. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685\u20138.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1450_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"1450_CR27","doi-asserted-by":"publisher","first-page":"1718741","DOI":"10.1155\/2019\/1718741","volume":"2019","author":"A Hatch","year":"2019","unstructured":"Hatch A, Horne J, Toma R, Twibell BL, Somerville KM, Pelle B, et al. A robust metatranscriptomic technology for population-scale studies of diet, gut microbiome, and human health. Int J Genomics. 2019;2019:1718741.","journal-title":"Int J Genomics"},{"issue":"8","key":"1450_CR28","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nbt.2942","volume":"32","author":"J Li","year":"2014","unstructured":"Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol. 2014;32(8):834\u201341.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"1450_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11306-018-1420-2","volume":"14","author":"KT Do","year":"2018","unstructured":"Do KT, Wahl S, Raffler J, Molnos S, Laimighofer M, Adamski J, et al. Characterization of missing values in untargeted MS-based metabolomics data and evaluation of missing data handling strategies. Metabolomics. 2018;14(10):128.","journal-title":"Metabolomics"},{"issue":"1","key":"1450_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118\u201327.","journal-title":"Biostatistics"},{"issue":"1","key":"1450_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12859-018-2263-6","volume":"19","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Jenkins DF, Manimaran S, Johnson WE. Alternative empirical Bayes models for adjusting for batch effects in genomic studies. BMC Bioinformatics. 2018;19(1):262.","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"1450_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/mas.21672","volume":"41","author":"W Han","year":"2022","unstructured":"Han W, Li L. Evaluating and minimizing batch effects in metabolomics. Mass Spectrom Rev. 2022;41(3):421\u201342.","journal-title":"Mass Spectrom Rev"},{"key":"1450_CR33","doi-asserted-by":"publisher","first-page":"38881","DOI":"10.1038\/srep38881","volume":"6","author":"B Li","year":"2016","unstructured":"Li B, Tang J, Yang Q, Cui X, Li S, Chen S, et al. Performance evaluation and online realization of data-driven normalization methods used in LC\/MS based untargeted metabolomics analysis. Sci Rep. 2016;6:38881.","journal-title":"Sci Rep"},{"issue":"4","key":"1450_CR34","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One. 2013;8(4):e61217.","journal-title":"PLoS One"},{"issue":"1","key":"1450_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1890\/0012-9615(1999)069[0001:DBRATM]2.0.CO;2","volume":"69","author":"P Legendre","year":"1999","unstructured":"Legendre P, Anderson MJ. Distance-based redundancy analysis: testing multispecies responses in multifactorial ecological experiments. Ecological Monographs. 1999;69(1):1\u201324.","journal-title":"Ecological Monographs"},{"issue":"1","key":"1450_CR36","first-page":"32","volume":"26","author":"MJ Anderson","year":"2001","unstructured":"Anderson MJ. A new method for non-parametric multivariate analysis of variance. Austral Ecol. 2001;26(1):32\u201346.","journal-title":"Austral Ecol"},{"issue":"11","key":"1450_CR37","doi-asserted-by":"publisher","first-page":"e1009442","DOI":"10.1371\/journal.pcbi.1009442","volume":"17","author":"H Mallick","year":"2021","unstructured":"Mallick H, Rahnavard A, McIver LJ, Ma S, Zhang Y, Nguyen LH, et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol. 2021;17(11):e1009442.","journal-title":"PLoS Comput Biol"},{"issue":"Suppl_1","key":"1450_CR38","doi-asserted-by":"publisher","first-page":"i34","DOI":"10.1093\/bioinformatics\/btab327","volume":"37","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Thompson KN, Huttenhower C, Franzosa EA. Statistical approaches for differential expression analysis in metatranscriptomics. Bioinformatics. 2021;37(Suppl_1):i34\u201341.","journal-title":"Bioinformatics"},{"issue":"43","key":"1450_CR39","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1450_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.chom.2016.12.014","volume":"21","author":"O Manor","year":"2017","unstructured":"Manor O, Borenstein E. Systematic characterization and analysis of the taxonomic drivers of functional shifts in the human microbiome. Cell Host Microbe. 2017;21(2):254\u201367.","journal-title":"Cell Host Microbe"},{"key":"1450_CR41","doi-asserted-by":"publisher","unstructured":"Noecker CE, Eng A, Borenstein E. MIMOSA2: a metabolic network-based tool for inferring mechanism-supported relationships in microbiome-metabolome data. BioRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.09.14.459910v1.","DOI":"10.1101\/2021.09.14.459910v1"},{"issue":"1","key":"1450_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L, et al. Mach Learn. 2001;45(1):5\u201332.","journal-title":"Mach Learn"},{"issue":"22","key":"1450_CR43","doi-asserted-by":"publisher","first-page":"E2329","DOI":"10.1073\/pnas.1319284111","volume":"111","author":"EA Franzosa","year":"2014","unstructured":"Franzosa EA, Morgan XC, Segata N, Waldron L, Reyes J, Earl AM, et al. Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci U S A. 2014;111(22):E2329\u201338.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1450_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12934-017-0735-4","volume":"16","author":"RA Gonzalez-Garcia","year":"2017","unstructured":"Gonzalez-Garcia RA, McCubbin T, Wille A, Plan M, Nielsen LK, Marcellin E. Awakening sleeping beauty: production of propionic acid in Escherichia coli through the sbm operon requires the activity of a methylmalonyl-CoA epimerase. Microb Cell Fact. 2017;16(1):121.","journal-title":"Microb Cell Fact"},{"issue":"1","key":"1450_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","volume":"19","author":"P Louis","year":"2017","unstructured":"Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19(1):29\u201341.","journal-title":"Environ Microbiol"},{"issue":"6","key":"1450_CR46","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/j.1365-2958.2006.05334.x","volume":"61","author":"MA Adams","year":"2006","unstructured":"Adams MA, Singh VK, Keller BO, Jia Z. Structural and biochemical characterization of gentisate 1,2-dioxygenase from Escherichia coli O157:H7. Mol Microbiol. 2006;61(6):1469\u201384.","journal-title":"Mol Microbiol"},{"issue":"1","key":"1450_CR47","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/HYPERTENSIONAHA.119.13155","volume":"74","author":"MU Cheema","year":"2019","unstructured":"Cheema MU, Pluznick JL. Gut microbiota plays a central role to modulate the plasma and fecal metabolomes in response to angiotensin II. Hypertension. 2019;74(1):184\u201393.","journal-title":"Hypertension"},{"issue":"15","key":"1450_CR48","doi-asserted-by":"publisher","first-page":"11714","DOI":"10.1074\/jbc.M109.064618","volume":"285","author":"IS Fernandez","year":"2010","unstructured":"Fernandez IS, Cuevas P, Angulo J, Lopez-Navajas P, Canales-Mayordomo A, Gonzalez-Corrochano R, et al. Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors. J Biol Chem. 2010;285(15):11714\u201329.","journal-title":"J Biol Chem"},{"issue":"4","key":"1450_CR49","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/dvdy.24491","volume":"246","author":"S Danopoulos","year":"2017","unstructured":"Danopoulos S, Schlieve CR, Grikscheit TC, Al Alam D. Fibroblast growth factors in the gastrointestinal tract: twists and turns. Dev Dyn. 2017;246(4):344\u201352.","journal-title":"Dev Dyn"},{"key":"1450_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.anaerobe.2013.07.009","volume":"23","author":"SG Parkar","year":"2013","unstructured":"Parkar SG, Trower TM, Stevenson DE. Fecal microbial metabolism of polyphenols and its effects on human gut microbiota. Anaerobe. 2013;23:12\u20139.","journal-title":"Anaerobe"},{"issue":"1","key":"1450_CR51","doi-asserted-by":"publisher","first-page":"13670","DOI":"10.1038\/s41598-017-13722-4","volume":"7","author":"T Pallister","year":"2017","unstructured":"Pallister T, Jackson MA, Martin TC, Zierer J, Jennings A, Mohney RP, et al. Hippurate as a metabolomic marker of gut microbiome diversity: Modulation by diet and relationship to metabolic syndrome. Sci Rep. 2017;7(1):13670.","journal-title":"Sci Rep"},{"issue":"10","key":"1450_CR52","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41587-019-0233-9","volume":"37","author":"T Wilmanski","year":"2019","unstructured":"Wilmanski T, Rappaport N, Earls JC, Magis AT, Manor O, Lovejoy J, et al. Blood metabolome predicts gut microbiome alpha-diversity in humans. Nat Biotechnol. 2019;37(10):1217\u201328.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"1450_CR53","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/jn\/133.6.1853","volume":"133","author":"MP Gonthier","year":"2003","unstructured":"Gonthier MP, Verny MA, Besson C, Remesy C, Scalbert A. Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J Nutr. 2003;133(6):1853\u20139.","journal-title":"J Nutr"},{"issue":"2","key":"1450_CR54","doi-asserted-by":"publisher","first-page":"e0149207","DOI":"10.1371\/journal.pone.0149207","volume":"11","author":"JL Jacobi","year":"2016","unstructured":"Jacobi JL, Yang B, Li X, Menze AK, Laurentz SM, Janle EM, et al. Impacts on sirtuin function and bioavailability of the dietary bioactive compound dihydrocoumarin. PLoS One. 2016;11(2):e0149207.","journal-title":"PLoS One"},{"issue":"1","key":"1450_CR55","doi-asserted-by":"publisher","first-page":"6000","DOI":"10.1038\/s41467-021-26209-8","volume":"12","author":"Y Lai","year":"2021","unstructured":"Lai Y, Liu CW, Yang Y, Hsiao YC, Ru H, Lu K. High-coverage metabolomics uncovers microbiota-driven biochemical landscape of interorgan transport and gut-brain communication in mice. Nat Commun. 2021;12(1):6000.","journal-title":"Nat Commun"},{"key":"1450_CR56","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1471-2180-12-199","volume":"12","author":"M Bonnin-Jusserand","year":"2012","unstructured":"Bonnin-Jusserand M, Grandvalet C, Rieu A, Weidmann S, Alexandre H. Tyrosine-containing peptides are precursors of tyramine produced by Lactobacillus plantarum strain IR BL0076 isolated from wine. BMC Microbiol. 2012;12:199.","journal-title":"BMC Microbiol"},{"issue":"11","key":"1450_CR57","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1016\/j.celrep.2018.02.060","volume":"22","author":"S Fujisaka","year":"2018","unstructured":"Fujisaka S, Avila-Pacheco J, Soto M, Kostic A, Dreyfuss JM, Pan H, et al. Diet, genetics, and the gut microbiome drive dynamic changes in plasma metabolites. Cell Rep. 2018;22(11):3072\u201386.","journal-title":"Cell Rep"},{"issue":"11","key":"1450_CR58","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1017\/S0007114508123431","volume":"101","author":"KJ Broadley","year":"2009","unstructured":"Broadley KJ, Akhtar Anwar M, Herbert AA, Fehler M, Jones EM, Davies WE, et al. Effects of dietary amines on the gut and its vasculature. Br J Nutr. 2009;101(11):1645\u201352.","journal-title":"Br J Nutr"},{"issue":"2","key":"1450_CR59","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"JM Yano","year":"2015","unstructured":"Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264\u201376.","journal-title":"Cell"},{"issue":"2","key":"1450_CR60","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10571-019-00772-7","volume":"40","author":"K Bugda Gwilt","year":"2020","unstructured":"Bugda Gwilt K, Gonzalez DP, Olliffe N, Oller H, Hoffing R, Puzan M, et al. Actions of trace amines in the brain-gut-microbiome axis via trace amine-associated receptor-1 (TAAR1). Cell Mol Neurobiol. 2020;40(2):191\u2013201.","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"1450_CR61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/1099800420941255","volume":"23","author":"KJ Kamp","year":"2021","unstructured":"Kamp KJ, Cain KC, Utleg A, Burr RL, Raftery D, Luna RA, et al. Bile acids and microbiome among individuals with irritable bowel syndrome and healthy volunteers. Biol Res Nurs. 2021;23(1):65\u201374.","journal-title":"Biol Res Nurs"},{"issue":"2","key":"1450_CR62","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/09637486.2017.1343286","volume":"69","author":"FG Candido","year":"2018","unstructured":"Candido FG, Valente FX, Grzeskowiak LM, Moreira APB, Rocha D, Alfenas RCG. Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity. Int J Food Sci Nutr. 2018;69(2):125\u201343.","journal-title":"Int J Food Sci Nutr"},{"key":"1450_CR63","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.biochi.2017.06.015","volume":"141","author":"J Yao","year":"2017","unstructured":"Yao J, Rock CO. Exogenous fatty acid metabolism in bacteria. Biochimie. 2017;141:30\u20139.","journal-title":"Biochimie"},{"issue":"1","key":"1450_CR64","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40168-021-01018-9","volume":"9","author":"J Tap","year":"2021","unstructured":"Tap J, Storsrud S, Le Neve B, Cotillard A, Pons N, Dore J, et al. Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome. Microbiome. 2021;9(1):74.","journal-title":"Microbiome"},{"issue":"7","key":"1450_CR65","doi-asserted-by":"publisher","first-page":"e14513","DOI":"10.1097\/MD.0000000000014513","volume":"98","author":"Q Sun","year":"2019","unstructured":"Sun Q, Jia Q, Song L, Duan L. Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: a systematic review and meta-analysis. Medicine. 2019;98(7):e14513.","journal-title":"Medicine"},{"issue":"1","key":"1450_CR66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/j.gastro.2020.06.099","volume":"160","author":"WD Chey","year":"2021","unstructured":"Chey WD, Keefer L, Whelan K, Gibson PR. Behavioral and diet therapies in integrated care for patients with irritable bowel syndrome. Gastroenterology. 2021;160(1):47\u201362.","journal-title":"Gastroenterology"},{"issue":"4","key":"1450_CR67","doi-asserted-by":"publisher","first-page":"G405","DOI":"10.1152\/ajpgi.00316.2021","volume":"322","author":"SJ Keely","year":"2022","unstructured":"Keely SJ, Barrett KE. Intestinal secretory mechanisms and diarrhea. Am J Physiol Gastrointest Liver Physiol. 2022;322(4):G405\u201320.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"1450_CR68","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/gut.34.4.489","volume":"34","author":"KE Murray","year":"1993","unstructured":"Murray KE, Shaw KJ, Adams RF, Conway PL. Presence of N-acyl and acetoxy derivatives of putrescine and cadaverine in the human gut. Gut. 1993;34(4):489\u201393.","journal-title":"Gut"},{"issue":"1","key":"1450_CR69","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40168-019-0704-8","volume":"7","author":"K Oliphant","year":"2019","unstructured":"Oliphant K, Allen-Vercoe E. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome. 2019;7(1):91.","journal-title":"Microbiome"},{"key":"1450_CR70","doi-asserted-by":"crossref","unstructured":"Kaval KG, Garsin DA. Ethanolamine utilization in bacteria. mBio. 2018;9(1):e00066-18.","DOI":"10.1128\/mBio.00066-18"},{"issue":"1","key":"1450_CR71","doi-asserted-by":"publisher","first-page":"9794","DOI":"10.1038\/s41598-020-66558-w","volume":"10","author":"I Midenfjord","year":"2020","unstructured":"Midenfjord I, Polster A, Sjovall H, Friberg P, Tornblom H, Simren M. Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms. Sci Rep. 2020;10(1):9794.","journal-title":"Sci Rep"}],"container-title":["Microbiome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-022-01450-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40168-022-01450-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-022-01450-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T19:28:06Z","timestamp":1692300486000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbiomejournal.biomedcentral.com\/articles\/10.1186\/s40168-022-01450-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1450"],"URL":"https:\/\/doi.org\/10.1186\/s40168-022-01450-5","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.21203\/rs.3.rs-3273491\/v1","asserted-by":"subject"}]},"ISSN":["2049-2618"],"issn-type":[{"value":"2049-2618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"23 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Boards at each of two sites approved the protocols governing participants: UCLA (IRB#11-000069, IRB#11-002818, IRB#12-001802, IRB#14-000333, IRB#15-001591, IRB#16-000187) and University at Buffalo (IRB#030-745083). All subjects provided informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EAM is a scientific advisory board member of Danone, Axial Biotherapeutics, Amare, Mahana Therapeutics, Pendulum, Bloom Biosciences, Seed, and APC Microbiome Ireland. RT and MV are employees of Viome Life Sciences. JPJ, VL, MH, JSL, TSD, BDN, JML, AG, and KT do not have any disclosures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}